Related Experiment Video

Updated: Aug 17, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical

Silvia Del Ry1, Claudio Passino, Maristella Maltinti

  • 1Institute of Clinical Physiology, National Research Council, Pisa, Italy.

European Journal of Heart Failure
|June 1, 2005
PubMed

Insights

Plasma levels of C-type natriuretic peptide (CNP) increase with chronic heart failure (CHF) severity. Elevated CNP suggests a role in endothelial dysfunction in CHF patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • C-type natriuretic peptide (CNP) is structurally related to other natriuretic peptides but its role in chronic heart failure (CHF) remains controversial.
  • CNP is secreted by the endothelium and heart, suggesting potential involvement in cardiovascular regulation.

Purpose of the Study:

  • To investigate the role of CNP in CHF by measuring plasma CNP levels.
  • To assess the relationship between plasma CNP levels and the clinical severity and functional status of CHF patients.

Main Methods:

  • Prospective study of 133 CHF patients and 21 age-matched healthy controls.
  • Plasma CNP levels were measured using radioimmunoassay after solid-phase extraction.
  • Clinical severity was assessed using NYHA functional classification, and left ventricular ejection fraction (EF) was determined.

Main Results:

  • Plasma CNP levels were significantly elevated in CHF patients compared to healthy controls.
  • CNP levels increased progressively with worsening NYHA class (I to IV), indicating a correlation with clinical severity.
  • A significant positive correlation was observed between plasma CNP levels and left ventricular ejection fraction (EF).

Conclusions:

  • Elevated plasma CNP is associated with increased clinical and functional severity in CHF.
  • These findings suggest a pathophysiological role for CNP in CHF, potentially influencing endothelial vasomotor function due to its vasorelaxing properties.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...